Botanical and phytochemical therapy of acne: A systematic review

Phytotherapy Research

Volumn 28, Issue 8, 2014, Pages 1137-1152

  Fisk, Whitney A ^a   Lev Tov, Hadar A ^a,b   Sivamani, Raja K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

acne; alternative; botanical; herbs; phytochemical; plants

Indexed keywords

ALGAL EXTRACT; ANTI ACNE AGENT; AYURVEDIC DRUG; CHINESE DRUG; COPAIBA OIL; GREEN TEA EXTRACT; GUGULIPID EXTRACT; HERBACEOUS AGENT; KAMPO; LAURIC ACID; OCIMUM BASILICUM EXTRACT; OCIMUM GRATISSIMUM EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; RETINOL; ROSE WATER; TEA LOTION; TEA TREE OIL; UNCLASSIFIED DRUG;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; ANTIOXIDANT ACTIVITY; AYURVEDA; BASIL; BOTANY; CHINESE HERB; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG SAFETY; HUMAN; KRAMERIA; KRAMERIACEAE; OCIMUM GRATISSIMUM; PHYTOCHEMISTRY; PLANT ROOT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROSE; SEAWEED; SIGNAL TRANSDUCTION; SKIN IRRITATION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ACNE; ALTERNATIVE; BOTANICAL; HERBS; PHYTOCHEMICAL; PLANTS;

ACNE VULGARIS; CLINICAL TRIALS AS TOPIC; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RESEARCH DESIGN;

EID: 84905672671     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5125     Document Type: Review

References (100)

1. Abbasi MA, Kausar A, Aziz ur R, et al,. 2010. Preparation of new formulations of anti-acne creams and their efficacy. Afr J Pharm Pharmacol 4 (6): 298-303.
2. Abreu AC, McBain AJ, Simoes M,. 2012. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep 29 (9): 1007-1021.
3. Abulnaja KO,. 2009. Oxidant/antioxidant status in obese adolescent females with acne vulgaris. Indian J Dermatol 54 (1): 36-40.
4. Akamatsu H, Asada Y, Horio T,. 1997. Effect of keigai-rengyo-to, a Japanese Kampo medicine, on neutrophil functions: a possible mechanism of action of keigai-rengyo-to in acne. J Int Med Res 25 (5): 255-265.
5. Al-Shobaili HA, Alzolibani AA, Al Robaee AA, Meki AR, Rasheed Z,. 2013. Biochemical markers of oxidative and nitrosative stress in acne vulgaris: correlation with disease activity. Journal Clin Lab Anal 27 (1): 45-52.
6. Alexis AF,. 2008. Clinical considerations on the use of concomitant therapy in the treatment of acne. J Dermatolog Treat 19 (4): 199-209.
7. Ammon HP, Wahl MA,. 1991. Pharmacology of Curcuma longa. Planta Med 57 (1): 1-7.
8. Aqil F, Ahmad I,. 2007. Antibacterial properties of traditionally used Indian medicinal plants. Methods Find Exp Clin Pharmacol 29 (2): 79-92.
9. Balambal R, Thiruvengadam KV, Kameswarant L, Janaki VR, Thambiah AS,. 1985. Ocimum basilicum in acne vulgaris-a controlled comparison with a standard regime. J Assoc Physicians India 33 (8): 507-508.
10. Balasubramanian S, Eckert RL,. 2007. Keratinocyte proliferation, differentiation, and apoptosis-differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol 224 (3): 214-219.
11. Bassett IB, Pannowitz DL, Barnetson RSC,. 1990. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 153 (8): 455-458.
12. Beevers CS, Chen L, Liu L, et al,. 2009. Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res 69 (3): 1000-1008.
13. Beltrami B, Vassallo C, Berardesca E, Borroni G,. 2001. Antinflammatory, antimicrobial, comedolytic effects of a topical plant complex treatment in acne vulgaris: a clinical trial. J Appl Cosmetol 19 (1): 11-20.
14. Bilal A, Jahan N, Ahmed A, et al,. 2012. Phytochemical and pharmacological studies on Ocimum basilicum Linn-a review. Int J Cur Res Rev 4 (23): 73-83.
15. Bowe WP, Logan AC,. 2010. Clinical implications of lipid peroxidation in acne vulgaris: old wine in new bottles. Lipids Health Dis 9: 141.
16. Bowe WP, Patel N, Logan AC,. 2012. Acne vulgaris: the role of oxidative stress and the potential therapeutic value of local and systemic antioxidants. J Drugs Dermatol 11 (6): 742-746.
17. Brito PM, Devillard R, Negre-Salvayre A, et al,. 2009. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 205 (1): 126-134.
18. Brandt FS, Cazzaniga A, Hann M,. 2011 Cosmeceuticals: current trends and market analysis. Semin Cutan Med Surg 30 (3): 141-143.
19. Capitanio B, Sinagra JL, Weller RB, Brown C, Berardesca E,. 2012. Randomized controlled study of a cosmetic treatment for mild acne. Clin Exp Dermatol 37 (4): 346-349.
20. Carson CF, Hammer KA, Riley TV,. 2006. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19 (1): 50-62.
21. Chahal DS, Sivamani RK, Rivkah Isseroff R, Dasu MR,. 2013. Plant-based modulation of toll-like receptors: an emerging therapeutic model. Phytother Res 27 (10): 1423-1438.
22. Collier CN, Harper JC, Cafardi JA, et al,. 2008. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 58 (1): 56-59.
23. Da Silva AG, De Freitas Puziol P, Leitao RN, et al,. 2012. Application of the essential oil from copaiba (Copaifera langsdorffii desf.) for acne vulgaris: a double-blind, placebo controlled clinical trial. Altern Med Rev 17 (1): 69-75.
24. Dantuluri S, North-Lewis P, Karthik SV,. 2011. Gotu Kola induced hepatotoxicity in a child-need for caution with alternative remedies. Dig Liver Dis 43 (6): 500.
25. Docherty JJ, McEwen HA, Sweet TJ, Bailey E, Booth TD,. 2007. Resveratrol inhibition of Propionibacterium acnes. J Antimicrob Chemother 59 (6): 1182-1184.
26. Elsaie ML, Abdelhamid MF, Elsaaiee LT, Emam HM,. 2009. The efficacy of topical 2% green tea lotion in mild-to-moderate acne vulgaris. J Drugs Dermatol 8 (4): 358-364.
27. Elston DM,. 2009. Topical antibiotics in dermatology: emerging patterns of resistance. Dermatol Clin 27 (1): 25-31.
28. Enshaieh S, Jooya A, Siadat AH, Iraji F,. 2007. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol 73 (1): 22-25.
29. Fabbrocini G, Staibano S, De Rosa G, et al,. 2011. Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am J Clin Dermatol 12 (2): 133-141.
30. Fung HT, Fung CW, Kam CW,. 2003. Lead poisoning after ingestion of home-made Chinese medicines. Emerg Med (Fremantle) 15 (5-6): 518-520.
31. Grange PA, Chereau C, Raingeaud J, et al,. 2009. Production of superoxide anions by keratinocytes initiates P. acnes-induced inflammation of the skin. PLoS Pathog 5 (7): e1000527.
32. Haider A, Shaw JC,. 2004. Treatment of acne vulgaris. JAMA 292 (6): 726-735.
33. Higaki S, Morimatsu S, Morohashi M, Yamagishi T, Hasegawa Y,. 1997. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations. J Int Med Res 25 (6): 318-324.
34. Higaki S, Toyomoto T, Morohashi M,. 2002. Seijo-bofu-to, Jumi-haidoku-to and Toki-shakuyaku-san suppress rashes and incidental symptoms in acne patients. Drugs Exp Clin Res 28 (5): 193-196.
35. Holian O, Walter RJ,. 2001. Resveratrol inhibits the proliferation of normal human keratinocytes in vitro. J Cell Biochem Suppl Suppl 36: 55-62.
36. Humphrey S,. 2012. Antibiotic resistance in acne treatment. Skin Therapy Lett 17 (9): 1-3.
37. Iinuma K, Sato T, Akimoto N, et al,. 2009. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. J Invest Dermatol 129 (9): 2113-2119
38. Ingram, JR, Grindlay, DJC, Williams HC,. 2010. Management of acne vulgaris: an evidence-based update. Clin and Exp Dermatol 35 (4): 351-354.
39. Jadad AR, Moore RA, Carroll D, et al,. 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 (1): 1-12.
40. Jagdeo J, Adams L, Lev-Tov H, et al,. 2010. Dose-dependent antioxidant function of resveratrol demonstrated via modulation of reactive oxygen species in normal human skin fibroblasts in vitro. J Drugs Dermatol 9 (12): 1523-1526.
41. Jain A, Basal E,. 2003. Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs. Phytomedicine 10 (1): 34-38.
42. Jeena K, Liju VB, Kuttan R,. 2013. Antioxidant, anti-inflammatory and antinociceptive activities of essential oil from ginger. Indian J Physiol Pharmacol 57 (1): 51-62.
43. Jiang H, Shang X, Wu H, et al,. 2009. Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. J Exp Ther Oncol 8 (1): 25-33.
44. Jordan SA, Cunningham DG, Marles RJ,. 2010. Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol 243 (2): 198-216.
45. Jung MK, Ha S, Son JA, et al,. 2012. Polyphenon-60 displays a therapeutic effect on acne by suppression of TLR2 and IL-8 expression via down-regulating the ERK1/2 pathway. Arch Dermatol Res 304 (8): 655-663.
46. Kamangar F, Shinkai K,. 2012. Acne in the adult female patient: a practical approach. Int J Dermatol 51 (10): 1162-1174.
47. Keane FM, Munn SE, Vivier AW, Higgins EM, Taylor NF,. 1999. Analysis of Chinese herbal creams prescribed for dermatological conditions. West J Med 170 (5): 257-259.
48. Kessler RC, Davis RB, Foster DF, et al,. 2001. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135 (4): 262-268.
49. Kim J, Ochoa MT, Krutzik SR, et al. 2002. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169 (3): 1535-1541.
50. Kim KS, Kim YB,. 2012. Anti-inflammatory effect of keigai-rengyo-to extract and acupuncture in male patients with acne vulgaris: a randomized controlled pilot trial. J Altern Complement Med 18 (5): 501-508.
51. Kumaran A, Karunakaran RJ,. 2006. Nitric oxide radical scavenging active components from Phyllanthus emblica L. Plant Foods Hum Nutr 61 (1): 1-5.
52. Lacarrubba F, Verzì AE, Tedeschi A, Catalfo P, Nasca MR, Micali G,. 2013. Clinical and ultrasonographic correlation of acne scars. Dermatol Surg 39 (11): 1683-1688.
53. Lalla JK, Nandedkar SY, Paranjape MH, Talreja NB,. 2001. Clinical trials of ayurvedic formulations in the treatment of acne vulgaris. J Ethnopharmacol 78 (1): 99-102.
54. Laplante M, Sabatini DM,. 2012. mTOR signaling in growth control and disease. Cell 149 (2): 274-293.
55. Lee SE, Kim JM, Jeong SK, et al,. 2010. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arch Dermatol Res 302 (10): 745-756.
56. Lee HE, Ko JY, Kim YH, et al,. 2011. A double-blind randomized controlled comparison of apddr-0901, a novel cosmeceutical formulation, and 0.1% adapalene gel in the treatment of mild-to-moderate acne vulgaris. Eur J Dermatol 21 (6): 959-965.
57. Lee HR, Kim SW, Kim MS, et al,. 2013. The efficacy and safety of gamma-linolenic acid for the treatment of acne vulgaris. Int J Dermatol. DOI: 10.1111/ijd.12026
58. Liu W, Shen D, Song P, Xu X,. 2003. Clinical observation in 86 cases of acne vulgaris treated with Compound Oldenlandis Mixture. J Tradit Chin Med 23 (4): 255-256.
59. Lone AH, Habib S, Ahmad T, Anwar M,. 2012. Effect of a polyherbal Unani formulation in acne vulgaris: a preliminary study. J Ayurveda Integr Med 3 (4): 180-183.
60. Lowenstein EB, Lowenstein EJ,. 2011. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero. Clin Dermatol 29 (6): 652-661.
61. Mahmood T, Akhtar N, Khan BA, Khan HM, Saeed T,. 2010. Outcomes of 3% green tea emulsion on skin sebum production in male volunteers. Bosn J Basic Med Sci 10 (3): 260-264.
62. Melnik B,. 2012. Dietary intervention in acne: attenuation of increased mTORC1 signaling promoted by Western diet. Dermatoendocrinol 4 (1): 20-32.
63. Mohd Nor NH, Aziz Z,. 2013. A systematic review of benzoyl peroxide for acne vulgaris. The J Dermatolog Treat 24 (5): 377-386.
64. Muizzuddin N, Schnittger S, Maher W, Maes DH, Mammone T,. 2013. Enzymatically generated hydrogen peroxide reduces the number of acne lesions in acne vulgaris. J Cosmet Sci 64 (1): 1-8.
65. Olivo SA, Macedo LG, Gadotti IC, et al,. 2008. Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther 88 (2): 156-175.
66. Orafidiya LO, Oyedele AO, Shittu AA, Elujoba AA,. 2001. The formulation of an effective topical antibacterial product containing Ocimum gratissimum leaf essential oil. Int J Pharm 224 (1-2): 177-183
67. Orafidiya LO, Agbani EO, Oyedele AO, et al,. 2002. Preliminary clinical tests on topical preparations of Ocimum gratissimum Linn leaf essential oil for the treatment of acne vulgaris. Clin Drug Investig 22 (5): 313-319.
68. Orafidiya LO, Agbani EO, Oyedele AO, et al,. 2004. The effect of aloe vera gel on the anti-acne properties of the essential oil of Ocimum gratissimum Linn leaf-a preliminary clinical investigation. Int J Aromather 14 (1): 15-21.
69. Pan H,. 2005. Thirty-two cases of acne treated with blood-letting puncture, cupping and Chinese-drug facemask. J Tradit Chin Med 25 (4): 270-272.
70. Paranjpe P, Kulkarni PH,. 1995. Comparative efficacy of four Ayurvedic formulations in the treatment of acne vulgaris: a double-blind randomised placebo-controlled clinical evaluation. J Ethnopharmacol 49 (3): 127-132.
71. Pawin H, Chivot M, Beylot C, et al,. 2007. Living with acne. A study of adolescents' personal experiences. Dermatol 215 (4): 308-314.
72. Pazyar N, Yaghoobi R, Bagherani N, Kazerouni A,. 2012. A review of applications of tea tree oil in dermatology. Int J Dermatol 52 (7): 784-790.
73. Rao J,. 2011. Treatment of acne scarring. Facial Plast Surg Clin North Am 19 (2): 275-291.
74. Ramli R, Malik AS, Hani AF, Jamil A,. 2012. Acne analysis, grading and computational assessment methods: an overview. Skin Res Technol 18 (1): 1-14.
75. Rathod M, Kamath S,. 2012. A clinical study to evaluate the efficacy of jalaukavacharana and sarivadyasava in yuvanapidaka (acne vulgaris). Int Res J Pharm 3 (7): 215-217.
76. Reinke A, Chen JC, Aronova S, Powers T,. 2006. Caffeine targets TOR complex I and provides evidence for a regulatory link between the FRB and kinase domains of Tor1p. J Biol Chem 281 (42): 31616-31626.
77. Riddle CC, Terrell SN, Menser MB, Aires DJ, Schweiger ES,. 2009. A review of photodynamictherapy (PDT) for the treatment of acne vulgaris. J Drugs Dermatol 8 (11): 1010-1019.
78. Rubel DM, Freeman S, Southwell IA,. 1998. Tea tree oil allergy: what is the offending agent? Report of three cases of tea tree oil allergy and review of the literature. Australas J Dermatol 39 (4): 244-247.
79. Rutherford T, Nixon R, Tam M, Tate B,. 2007. Allergy to tea tree oil: retrospective review of 41 cases with positive patch tests over 4.5 years. Australas J Dermatol 48 (2): 83-87.
80. Saha H,. 2012. Cosmeceuticals and herbal drugs: practical uses. Int J Pharm Sci Res 3 (1): 59-65.
81. Sarici G, Cinar S, Armutcu F, et al,. 2010. Oxidative stress in acne vulgaris. J Eur Acad Dermatol 24 (7): 763-767.
82. Selvaag E, Eriksen B, Thune P,. 1994. Contact allergy due to tea tree oil and cross-sensitization to colophony. Contact Dermat 31 (2): 124-125.
83. Sharquie KE, Al-Turfi IA, Al-Shimary WM,. 2006. Treatment of acne vulgaris with 2% topical tea lotion. Saudi Med J 27 (1): 83-85.
84. Sharquie KE, Noaimi AA, Al-Salih MM,. 2008. Topical therapy of acne vulgaris using 2% tea lotion in comparison with 5% zinc sulphate solution. Saudi Med J 29 (12): 1757-1761.
85. Simonart T, Dramaix M,. 2005. Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol 153 (2): 395-403.
86. Sparavigna A, Setaro M, Sormani S, Bergamaschi M,. 2006. Dermatological and instrumental evaluation of the activity of a new dermocosmetic product adjuvant in the treatment of acne. G Ital Dermatol Venereol 141 (5): 439-448.
87. Subbaramaiah K, Chung WJ, Michaluart P, et al,. 1998. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273 (34): 21875-21882.
88. Sundin T, Hentosh P,. 2012. InTERTesting association between telomerase, mTOR and phytochemicals. Expert Rev Mol Med 14. DOI: 10.1017/erm.2012.1.
89. Tan J, Wolfe B, Weiss J, et al,. 2012. Acne severity grading: determining essential clinical components and features using a Delphi consensus. J Am Acad Dermatol 67 (2): 187-193.
90. Tang FY, Cho HJ, Pai MH, Chen YH,. 2009. Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J Nutr Biochem 20 (6): 426-434.
91. Tanghetti EA, Popp KF,. 2009. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin 27 (1): 17-24.
92. Taylor PW, Hamilton-Miller JM, Stapleton PD,. 2005. Antimicrobial properties of green tea catechins. Food Sci Technol Bull 2: 71-81.
93. Thappa DM, Dogra J,. 1994. Nodulocystic acne: oral gugulipid versus tetracycline. J Dermatol 21 (10): 729-731.
94. Thiboutot D,. 2011. Dermatologists do not yet fully understand the clinical significance of antibiotic use and bacterial resistance in patients with acne: comment on "Antibiotics, acne, and Staphylococcus aureus colonization". Arch Dermatol 147 (8): 921-922.
95. Thiboutot D, Gollnick H, Bettoli V, et al,. 2009. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne Group. J Am Acad Dermatol 60 (5, Supplement 1): S1-S50.
96. Titus S, Hodge J,. 2012. Diagnosis and treatment of acne. Am Fam Physician 86 (8): 734-740.
97. Tovar RT, Petzel RM,. 2009. Herbal toxicity. Dis Mon 55 (10): 592-641.
98. Uslu G, Sendur N, Uslu M, et al,. 2008. Acne: prevalence, perceptions and effects on psychological health among adolescents in Aydin, Turkey. J Eur Acad Dermatol Venereol 22 (4): 462-469.
99. Witkowski JA, Parish LC,. 2004. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol 22 (5): 394-397.
100. Yoon JY, Kwon HH, Min SU, Thiboutot DM, Suh DH,. 2013. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes. J Invest Dermatol 133 (2): 429-440.